Paxlovid

Paxlovid decreased hospitalisation, risk of death during Omicron wave: Research

Read more

China allows sale of Pfizer oral drug as demand surges in wake of rising COVID cases

Read more

Hetero’s ‘NIRMACOM’ gets WHO Prequalification for COVID-19 treatment

Read more

China Meheco to distribute Pfizer’s COVID treatment in China

Read more

US to pay Pfizer nearly $2 billion for more Paxlovid courses in 2023

Read more

Pfizer sees $10-$15 billion in annual mRNA vaccine revenue by 2030

Read more

US government to test Pfizer’s Paxlovid for long COVID

Read more

Zenara Pharma launches Paxlovid generic for COVID-19 in India

Read more

Pfizer to spend $120 million to boost US COVID pill manufacturing

Read more

WHO recommends Pfizer’s Paxlovid for wide geographical distribution

Read more